 Antigens, CD
"Antigens, CD" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.
| Descriptor ID |
D015703
|
| MeSH Number(s) |
D23.050.301.264.035 D23.101.100.110
|
| Concept/Terms |
Antigens, CD- Antigens, CD
- CD Antigens
- Cluster of Differentiation Markers
- Cluster of Differentiation Antigens
|
Below are MeSH descriptors whose meaning is more general than "Antigens, CD".
Below are MeSH descriptors whose meaning is more specific than "Antigens, CD".
- Antigens, CD
- 5'-Nucleotidase
- Activated-Leukocyte Cell Adhesion Molecule
- Antigens, CD1
- Antigens, CD11
- Antigens, CD13
- Antigens, CD137
- Antigens, CD14
- Antigens, CD146
- Antigens, CD147
- Antigens, CD15
- Antigens, CD151
- Antigens, CD164
- Antigens, CD18
- Antigens, CD19
- Antigens, CD2
- Antigens, CD20
- Antigens, CD24
- Antigens, CD27
- Antigens, CD28
- Antigens, CD29
- Antigens, CD3
- Antigens, CD30
- Antigens, CD31
- Antigens, CD34
- Antigens, CD36
- Antigens, CD38
- Antigens, CD4
- Antigens, CD40
- Antigens, CD43
- Antigens, CD45
- Antigens, CD46
- Antigens, CD47
- Antigens, CD5
- Antigens, CD53
- Antigens, CD55
- Antigens, CD56
- Antigens, CD57
- Antigens, CD58
- Antigens, CD59
- Antigens, CD63
- Antigens, CD7
- Antigens, CD70
- Antigens, CD79
- Antigens, CD8
- Antigens, CD81
- Antigens, CD82
- Antigens, CD9
- Antigens, CD95
- Antigens, CD98
- Antigens, Thy-1
- B-Cell Activation Factor Receptor
- B7 Antigens
- CD30 Ligand
- CD40 Ligand
- CTLA-4 Antigen
- Cytokine Receptor Common beta Subunit
- Cytokine Receptor gp130
- Dipeptidyl Peptidase 4
- Fas Ligand Protein
- fms-Like Tyrosine Kinase 3
- Inducible T-Cell Co-Stimulator Protein
- Integrin alpha1
- Integrin alpha2
- Integrin alpha3
- Integrin alpha4
- Integrin alpha5
- Integrin alpha6
- Integrin alphaV
- Integrin beta3
- Integrin beta4
- Intercellular Adhesion Molecule-1
- Interleukin Receptor Common gamma Subunit
- Interleukin-10 Receptor alpha Subunit
- Interleukin-10 Receptor beta Subunit
- Interleukin-13 Receptor alpha1 Subunit
- Interleukin-13 Receptor alpha2 Subunit
- Interleukin-18 Receptor alpha Subunit
- Interleukin-18 Receptor beta Subunit
- Interleukin-2 Receptor alpha Subunit
- Interleukin-2 Receptor beta Subunit
- Interleukin-3 Receptor alpha Subunit
- Interleukin-4 Receptor alpha Subunit
- Interleukin-5 Receptor alpha Subunit
- Interleukin-6 Receptor alpha Subunit
- Interleukin-7 Receptor alpha Subunit
- Junctional Adhesion Molecule A
- Junctional Adhesion Molecule B
- Leukemia Inhibitory Factor Receptor alpha Subunit
- Low Density Lipoprotein Receptor-Related Protein-1
- Lysosomal-Associated Membrane Protein 1
- Lysosomal-Associated Membrane Protein 2
- Lysosomal-Associated Membrane Protein 3
- Mucin-1
- Natural Cytotoxicity Triggering Receptor 1
- Natural Cytotoxicity Triggering Receptor 2
- Natural Cytotoxicity Triggering Receptor 3
- Neprilysin
- NK Cell Lectin-Like Receptor Subfamily B
- NK Cell Lectin-Like Receptor Subfamily D
- NK Cell Lectin-Like Receptor Subfamily K
- Peptidyl-Dipeptidase A
- Platelet Membrane Glycoprotein IIb
- Programmed Cell Death 1 Receptor
- Proto-Oncogene Proteins c-kit
- Receptor, Anaphylatoxin C5a
- Receptor, ErbB-2
- Receptor, Macrophage Colony-Stimulating Factor
- Receptors, Chemokine
- Receptors, Complement 3b
- Receptors, Complement 3d
- Receptors, IgE
- Receptors, IgG
- Receptors, Interleukin-1 Type I
- Receptors, Interleukin-1 Type II
- Receptors, Interleukin-17
- Receptors, Interleukin-7
- Receptors, Interleukin-8A
- Receptors, Interleukin-9
- Receptors, KIR2DL1
- Receptors, KIR2DL2
- Receptors, KIR2DL3
- Receptors, KIR2DL4
- Receptors, KIR3DL1
- Receptors, KIR3DL2
- Receptors, Lymphocyte Homing
- Receptors, OX40
- Receptors, Thrombopoietin
- Receptors, Tumor Necrosis Factor, Type I
- Receptors, Tumor Necrosis Factor, Type II
- Receptors, Urokinase Plasminogen Activator
- Selectins
- Sialic Acid Binding Immunoglobulin-like Lectins
- Syndecan-1
- Transmembrane Activator and CAML Interactor Protein
- Vascular Cell Adhesion Molecule-1
This graph shows the total number of publications written about "Antigens, CD" by people in this website by year, and whether "Antigens, CD" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 0 | 1 | 1 | | 1990 | 0 | 1 | 1 | | 1991 | 0 | 1 | 1 | | 1992 | 0 | 2 | 2 | | 1993 | 0 | 2 | 2 | | 1994 | 0 | 3 | 3 | | 1995 | 0 | 2 | 2 | | 1996 | 0 | 1 | 1 | | 1997 | 1 | 1 | 2 | | 1998 | 1 | 0 | 1 | | 1999 | 2 | 1 | 3 | | 2000 | 1 | 4 | 5 | | 2001 | 0 | 1 | 1 | | 2002 | 1 | 2 | 3 | | 2004 | 0 | 3 | 3 | | 2005 | 0 | 1 | 1 | | 2006 | 0 | 7 | 7 | | 2007 | 1 | 3 | 4 | | 2008 | 1 | 4 | 5 | | 2009 | 2 | 3 | 5 | | 2010 | 1 | 2 | 3 | | 2011 | 1 | 1 | 2 | | 2012 | 1 | 1 | 2 | | 2013 | 1 | 3 | 4 | | 2014 | 0 | 2 | 2 | | 2015 | 2 | 5 | 7 | | 2016 | 1 | 1 | 2 | | 2017 | 0 | 3 | 3 | | 2018 | 1 | 0 | 1 | | 2019 | 0 | 1 | 1 | | 2020 | 0 | 1 | 1 | | 2021 | 2 | 0 | 2 | | 2022 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Antigens, CD" by people in Profiles.
-
Duan L, Perez RE, Calhoun S, Maki CG. Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF15. Cancer Biol Ther. 2022 12 31; 23(1):65-75.
-
Bunet R, Nayrac M, Ramani H, Sylla M, Durand M, Chartrand-Lefebvre C, Routy JP, Landay AL, Gauchat JF, Chomont N, Ancuta P, Kaufmann DE, Bernard N, Tremblay CL, El-Far M. Loss of CD96 Expression as a Marker of HIV-Specific CD8+ T-Cell Differentiation and Dysfunction. Front Immunol. 2021; 12:673061.
-
Zhang Y, Tian Z, Gerard D, Yao L, Shofer FS, Cs-Szabo G, Qin L, Pacifici M, Enomoto-Iwamoto M. Elevated inflammatory gene expression in intervertebral disc tissues in mice with ADAM8 inactivated. Sci Rep. 2021 01 19; 11(1):1804.
-
Kamkwalala AR, Wang X, Maki PM, Williams DW, Valcour VG, Damron A, Tien PC, Weber KM, Cohen MH, Sundermann EE, Meyer VJ, Little DM, Xu Y, Rubin LH. Brief Report: Higher Peripheral Monocyte Activation Markers Are Associated With Smaller Frontal and Temporal Cortical Volumes in Women With HIV. J Acquir Immune Defic Syndr. 2020 05 01; 84(1):54-59.
-
Jones RL, Chawla SP, Attia S, Sch?ffski P, Gelderblom H, Chmielowski B, Le Cesne A, Van Tine BA, Trent JC, Patel S, Wagner AJ, Chugh R, Heyburn JW, Weil SC, Wang W, Viele K, Maki RG. A phase 1 and randomized controlled phase 2 trial of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft-tissue sarcomas. Cancer. 2019 07 15; 125(14):2445-2454.
-
Yu Y, Blokhuis BRJ, Diks MAP, Keshavarzian A, Garssen J, Redegeld FA. Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells. Front Immunol. 2018; 9:2138.
-
Wallace J, Lutgen V, Avasarala S, St Croix B, Winn RA, Al-Harthi L. Wnt7a induces a unique phenotype of monocyte-derived macrophages with lower phagocytic capacity and differential expression of pro- and anti-inflammatory cytokines. Immunology. 2018 02; 153(2):203-213.
-
Njoroge SW, Burgess KR, Cobleigh MA, Alnajar HH, Gattuso P, Usha L. Hereditary diffuse gastric cancer and lynch syndromes in a BRCA1/2 negative breast cancer patient. Breast Cancer Res Treat. 2017 Nov; 166(1):315-319.
-
Judge CJ, Kostadinova L, Sherman KE, Butt AA, Falck-Ytter Y, Funderburg NT, Landay AL, Lederman MM, Sieg SF, Sandberg JK, Anthony DD. CD56bright NK IL-7Ra expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections. J Leukoc Biol. 2017 07; 102(1):171-184.
-
Thway K, Robertson D, Jones RL, Selfe J, Shipley J, Fisher C, Isacke CM. Endosialin expression in soft tissue sarcoma as a potential marker of undifferentiated mesenchymal cells. Br J Cancer. 2016 08 09; 115(4):473-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|